BioNTech : Information pursuant to Section 125 AktG in conjunction with Article 4 (1) and Table 3 of Implementing Regulation (EU) 2018/1212

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

Disclosures pursuant to Sec. 125 (2) and (5) Sentence 1 German Stock Corporation Act ("AktG") in conjunction with Article 4 (1) and Table 3 of the Commission Implementing Regulation (EU) 2018/1212 ("EU-IR")

A. Specification of the message

		Annual General Meeting 2024 of BioNTech SE on
1.	Unique identifier of the event	17 May 2024
In the format pursuant to EU-IR:
		2008339965e7ee11b53000505696f23c
2.	Type of message	Invitation to Annual General Meeting
In the format pursuant to EU-IR: NEWM
B. Specification of the issuer
1.	ISIN	DE000A0V9BC4; US09075V1026
2.	Name of issuer	BioNTech SE
C. Specification of the meeting
1.	Date of the General Meeting	17 May 2024
In the format pursuant to EU-IR: 20240517
		14.00h (CEST)
2.	Time of the General Meeting
In the format pursuant to EU-IR: 12.00h UTC (Coordinated
		Universal Time)
		Annual General Meeting as virtual general meeting without
		physical presence of the shareholders or their authorized
3.	Type of the General Meeting	representatives (with the exception of the proxies ap-
		pointed by the Company)
		In the format pursuant to EU-IR: GMET
		Große Bleiche 54-56, 55116 Mainz
4.	Location of the General Meet-	Uniform Resource Locator (URL) to the investor portal to
ing	follow the General Meeting in audio and video and to exer-
		cise shareholders rights:
		https://investors.biontech.de/agm/agm-2024
		10 May 2024, 24.00h (CEST)
5.	Record Date
In the format pursuant to EU-IR: 20240510; 22.00h UTC
		(Coordinated Universal Time)
6.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL)
D. Participation in the general meeting - Electronical postal vote
	Method of participation by	Voting by electronic postal vote
1.
shareholder	In the format pursuant to EU-IR: EV
		Registration for the General Meeting by 10 May 2024,
2.	Issuer deadline for the notifi-	24.00h (CEST)
cation of participation	In the format pursuant to EU-IR: 20240510; 22.00h UTC
		(Coordinated Universal Time)
		1
		Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

3.

Issuer deadline for voting

For electronic voting via the investor portal at https://investors.biontech.de/agm/agm-2024:

until the time the vote is closed by the chairman of the meeting at the virtual General Meeting on 17 May 2024.

In the format pursuant to EU-IR: 20240517; until the time the vote is closed by the chairman of the meeting

D. Participation in the general meeting - Participation through authorized representative

Exercising voting rights by

		•	Issuing authorization and instructions to the proxies
			appointed by the Company
		•	Issuing power of attorney and, if desired, instruc-
1.	Method of participation by		tions to other authorized representatives, including
shareholder		an intermediary, a shareholders' association, a vot-
			ing rights advisor or another person or institution
			equivalent to intermediaries pursuant to Sec. 135
			(8) AktG
		In the format pursuant to EU-IR: PX
		Registration for the General Meeting by 10 May 2024,
2.	Issuer deadline for the notifica-	24.00h (CEST)
tion of participation
In the format pursuant to EU-IR: 20240510; 22.00h UTC
		(Coordinated Universal Time)
		For the granting of power of attorney and instructions to the
		proxies appointed by the Company (as well as any amend-
		ment or revocation of granted powers of attorney with in-
		structions) by post or e-mail:
		For organizational reasons, should be sent by 16 May 2024,
		24.00h (CEST) at the latest, receipt relevant
		In the format pursuant to EU-IR: 20240516; 22.00h UTC
		(Coordinated Universal Time)
		For the electronic issuance of power of attorney and instruc-
		tions to the proxies appointed by the Company (as well as
		any amendment or revocation of proxies granted with in-
3.	Issuer deadline for voting	structions) via the password-protected Investor Portal at
https://investors.biontech.de/agm/agm-2024:
		Also on the day of the virtual General Meeting on 17 May
		2024 until the start of voting
		In the format pursuant to EU-IR: 20240517; until the start of
		voting
		For granting of power of attorney and, if desired, instructions
		to other authorized representatives, including an intermedi-
		ary, a shareholders' association, a voting advisor or another
		person or institution deemed equivalent to intermediaries
		pursuant to Sec. 135 (8) AktG (as well as their revocation)
		by post or e-mail:
			2
			Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

		For organizational reasons, should be sent by 16 May 2024,
		24.00h (CEST), receipt relevant
		In the format pursuant to EU-IR: 20240516; 22.00h UTC
		(Coordinated Universal Time)
		For the granting of power of attorney and, if desired, instruc-
		tions to other authorized representatives, including an inter-
		mediary, a shareholders' association, a voting advisor or
		any other person or institution deemed equivalent to inter-
		mediaries pursuant to Sec. 135 (8) AktG (as well as their
		revocation) via the password-protected Investor Portal at
		https://investors.biontech.de/agm/agm-2024:
		Also on the day of the virtual General Meeting on 17 May
		2024 until the start of voting
		In the format pursuant to EU-IR: 20240517; until the start of
		voting
E. Agenda - Agenda Item 1
1.	Unique identifier of the	1
agenda item
		Presentation of the adopted annual financial statements,
		the approved consolidated financial statements and the
2.	Title of the agenda item	combined management report for the Company and the
Group, as well as the report of the Supervisory Board, in
		each case for the 2023 financial year respectively as of
		31 December 2023
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	None
5.	Alternative voting options	None
E. Agenda - Agenda Item 2
1.	Unique identifier of the	2
agenda item
2.	Title of the agenda item	Resolution on the appropriation of the balance sheet profit
for the 2023 financial year
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 3
1.	Unique identifier of the	3
agenda item
2.	Title of the agenda item	Resolution on the approval of the actions of the Manage-
ment Board
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
		3
		Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

4.	Vote	Binding vote
In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 4
1.	Unique identifier of the	4
agenda item
2.	Title of the agenda item	Resolution on the approval of the actions of the Supervi-
sory Board
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant to EU-IR: BV
		YES, NO, ABSTENTION
5.	Alternative voting options
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 5
1.	Unique identifier of the	5
agenda item
		Resolution on the appointment of the auditor and the group
2.	Title of the agenda item	auditor for the 2024 financial year as well as the auditor for
		any audit or review of interim financial information
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 6
1.	Unique identifier of the	6
agenda item
2.	Title of the agenda item	Resolution on the approval of the Compensation Report
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Advisory vote
In the format pursuant to EU-IR: AV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 7
1.	Unique identifier of the	7
agenda item
		4
		Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

2.	Title of the agenda item	Resolution on the approval of the adjusted Compensation
System for members of the Management Board
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials

Advisory vote

4. Vote

In the format pursuant EU-IR: AV

YES, NO, ABSTENTION

5. Alternative voting options

		In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 8
1.	Unique identifier of the	8
agenda item
		Resolution on the adjustment of the Compensation System
2.	Title of the agenda item	and the compensation of the Supervisory Board members
as well as the corresponding amendment of Sec. 9 para. 6
		of the Articles of Association
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials

Binding vote

4. Vote

In the format pursuant to EU-IR: BV

YES, NO, ABSTENTION

5. Alternative voting options

		In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 9
1.	Unique identifier of the	9
agenda item
		Resolution on the cancellation of an existing authorization
		and the creation of a new authorization to issue bonds with
		warrants and/or convertible bonds and to exclude subscrip-
2.	Title of the agenda item	tion rights, together with the cancellation of the existing
		Conditional Capital WSV 2019 and the creation of a new
		Conditional Capital WSV 2024 as well as corresponding
		amendment to the Articles of Association
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
		Binding vote
4.	Vote
In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 10
1.	Unique identifier of the	10
agenda item
2.	Title of the agenda item	Resolution on the authorization to acquire treasury shares,
also excluding tender rights, and to use them, also
		5
		Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

		excluding subscription rights, as well as cancellation of the
		existing authorization
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials

Binding vote

4. Vote

In the format pursuant to EU-IR: BV

5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 11
1.	Unique identifier of the	11
agenda item
2.	Title of the agenda item	Resolution on the authorization to use derivatives in con-
nection with the acquisition of treasury shares
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 12
1.	Unique identifier of the	12
agenda item
2.	Title of the agenda item	Amendment of authorizations to issue stock options
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant to EU-IR: BV

YES, NO, ABSTENTION

5. Alternative voting options

			In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 13
1.	Unique identifier of the	13
agenda item
			Resolution on the partial cancellation and amendment of an
			authorization to issue stock options, the partial cancellation
			of the Conditional Capital ESOP 2017/2019 and ESOP
2.	Title of the agenda item	2021, the creation of a new authorization to issue stock op-
			tions (ESOP 2024) and a new Conditional Capital ESOP
			2024 and corresponding Amendments to the Articles of As-
			sociation
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
			6
			Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

		In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB
E. Agenda - Agenda Item 14
1.	Unique identifier of the	14
agenda item
		Resolution on the approval of the conclusion of a domina-
2.	Title of the agenda item	tion and profit and loss transfer agreement between BioN-
		Tech SE and BioNTech Collaborations GmbH
3.	Uniform Resource Locator	https://investors.biontech.de/agm/agm-2024
(URL) of the materials
4.	Vote	Binding vote
In the format pursuant to EU-IR: BV
5.	Alternative voting options	YES, NO, ABSTENTION
In the format pursuant to EU-IR: VF, VA, AB

F. Specification of the deadlines regarding the exercise of other shareholders rights - Supplementary motions

1.	Object of deadline	Supplementary motions (Art. 56 SE-Regulation, Sec. 50 (2)
German SE Implementation Act, Sec. 122 (2) AktG)
		16 April 2024, 24.00h (CEST)
2.	Applicable issuer deadline
In the format pursuant to EU-IR: 20240416; 22.00h UTC
		(Coordinated Universal Time)

F. Specification of the deadlines regarding the exercise of other shareholders rights - Countermotions

1.	Object of deadline	Sending of countermotions to a specific item of the agenda
(Sec. 126 (1), (4) AktG)
		2 May 2024, 24.00h (CEST)
2.	Applicable issuer deadline
In the format pursuant to EU-IR: 20240502; 22.00h UTC
		(Coordinated Universal Time)

F. Specification of the deadlines regarding the exercise of other shareholders rights - Election proposals

1.	Object of deadline	Submission of election proposals (Sec. 127 AktG)
		2 May 2024, 24.00h (CEST)
2.	Applicable issuer deadline
In the format pursuant to EU-IR: 20240502; 22.00h UTC
		(Coordinated Universal Time)

F. Specification of the deadlines regarding the exercise of other shareholders rights - Submission of statements

1.	Object of deadline	Submission of statements in text form (Sec. 118a (1) sen-
tence 2 no. 6, Sec. 130a (1) to (4) AktG)
		11 May 2024, 24.00h (CEST)
2.	Applicable issuer deadline
In the format pursuant to EU-IR: 20240511; 22.00h UTC
		(Coordinated Universal Time)
		7
		Germany 15279880.1

Annual General Meeting 2024 of BioNTech SE on 17 May 2024

F. Specification of the deadlines regarding the exercise of other shareholders rights - Right to speak, request information and submit motions

		Right to speak (Sec. 118a (1) sentence 2 no. 7, Sec. 130a
1.	Object of deadline	(5) and (6) AktG), right to information (Sec. 118a (1) sen-
tence 2 no. 4, Sec. 131 (1) AktG) and right to submit mo-
		tions (Sec. 118a (1) sentence 2 no. 3 AktG)
		Exclusively on the day of the virtual General Meeting on
		17 May 2024, from 14.00h (CEST) until the time set by the
2.	Applicable issuer deadline	chairman of the meeting
In the format pursuant to EU-IR: 20240517; from 12.00h
		UTC (Coordinated Universal Time) until the time set by the
		chairman of the meeting

F. Specification of the deadlines regarding the exercise of other shareholders rights - Objections to resolutions

		Electronical filing of objections to resolutions adopted by
1.	Object of deadline	the virtual General Meeting (Sec. 118a (1) sentence 2 no. 8
		AktG)
		17 May 2024, from opening of the General Meeting until
		closure by the chairman of the meeting via the investor por-
		tal accessible at
2.	Applicable issuer deadline	https://investors.biontech.de/agm/agm-2024
		In the format pursuant to EU-IR: 20240517; from opening of
		the General Meeting until closure by the chairman of the
		meeting

F. Specification of the deadlines regarding the exercise of other shareholders rights - Live audio and video broadcast of the General Meeting via the investor portal

		The General Meeting can be followed live in audio and
1.	Object of deadline	video via the investor portal available at
		https://investors.biontech.de/agm/agm-2024

17 May 2024, from 14.00h (CEST)

2. Applicable issuer deadline

In the format pursuant to EU-IR: 20240517; from 12.00h

UTC (Coordinated Universal Time)

8

Germany 15279880.1